| Poster Programme |
| P 1 |
How to choose a suit for a BSL4 laboratory - the approach taken at SPIEZ LABORATORY
D. Kuemin, S. Breitenbaumer, M. Strasser, M. Hofer, R. Liebi, P. Wick, L. Gyseler, C. Krebs, M. Schuetz, SPIEZ LABORATORY/CH |
| P 2 |
Successful decontamination of an HVAC system's ductwork using chlorine dioxide gas
M. Czarneski, Clordisys Solutions, Inc, Lebanon, OH/USA |
| P 3 |
Safety cabinets: the influence of dynamic interference factors on the safety function
T. Hinrichs, S. Gragert, B. Kamdem Medom, Berner International GmbH, Elmshorn/D |
| P 4 |
Predictive assumption and calculation of risk of chemical contamination using cytotoxic materials
D. Meyer, Getinge Life Sciences, Tournefeuille/F |
| P 5 |
Ethidiume bromide: is it really so dangerous?
D. Seger, Weizmann Institute of Science, Rehovot/IL |
| P 6 |
Lentiviral vectors: controlling the biosafety issues
D. Seger, Weizmann Institute of Science, Rehovot/IL |
| P 7 |
Microbiological safety cabinets - protective functions and their limits
T. Hinrichs, S. Christiansen, R. Karpinska, S. Gragert, Berner International GmbH, Elmshorn/D |
| P 9 |
Biosecurity measures used to control the quality of vaccines for oral immunization of wild carnivores against rabies
D.S. Surnev, G.S. Kantutis, D.N. Soloviev, JSC Pokrov Biological Plant, Volginskiy/RUS |
| P 10 |
Modeling the total cost of BSC ownership
D.S. Phillips, Thermo Fisher Scientfic, Arnold, MD/USA; M. Dunn, Thermo Fisher Scientific, Basingstoke/UK |
| P 11 |
Efficacy of a safety catheter needle system in the prevention of occupational needle-stick injuries: five-year retrospective study of its implementation
D. Sossai, L. Ruzza, A.M. Polimeni, A.O.U. San Martino di Genova/I; V. Puro, Istituto Spallanzani, Rome/I |
| P 12 |
BSL3 testing performance standards
P. Langevin, G. Tremblay, Merrick Canada ULC, Ottawa/CDN |
| P 13 |
Standard operating procedure: a living document
V. Viji, R.N. Mahalakshmi, National University of Singapore/SGP |
| P 14 |
Advancements is tissue digester design and technology
G. Schmidt, Progressive Recovery, Inc., Dupo, IL/USA |
| P 15 |
Chlamydophila (Chlamydia) psittaci, the causative agent of avian chlamydiosis and human psittacosis: risk assessment and biosafety recommendations
V. Dickx, Ghent University/B; C. Van Droogenbroeck, B. Van Vaerenbergh, P. Herman, Scientific Institute of Public Health, Brussels/B; L. Braeckman, D. Vanrompay, Ghent University/B |
| P 16 |
10 years of biorisk management: do's and don'ts
B. Verduin, Wageningen UR (University & Research centre)/NL |
| P 18 |
Studying immunogenicity of vaccine against highly-pathogenic avian influenza and newcastle disease to control in Ukraine
B. Stegniy, P. Shutchenko, M. Stegniy, D. Muzyka, A. Stegniy, NSC & IECVM, Kharkiv/UA |
| P 19 |
Swine brucellosis, epizootological monitoring, ssolation and identification of strains from pigs and wild boars, antigenic relation of isolated strains in Ukraine
B. Stegniy, A. Babkin, O. Kutsan, M. Stegniy, P. Shutchenko, NSC & IECVM, Kharkiv/UA |
| P 20 |
Brucellosis eradication and control in Ukraine
B. Stegniy, A. Babkin, A. Gerilovych, P. Shutchenko, NSC IECVM, Kharkiv/UA |
| P 21 |
qPCR for the detection and quantification of Adeno-Associated Virus Serotype 2 (AAV2) ITR-Sequences
C. Aurnhammer, M. Haase, Bavarian Health and Food Safety Authority, Oberschleissheim/D; N. Muether, M. Hausl, Max von Pettenkofer-Institute, Munich/D; I. Huber, Bavarian Health and Food Safety Authority, Oberschleissheim/D; N. Nitschko, Max von Pettenkofer-Institute, Munich/D; U. Busch, A. Sing, Bavarian Health and Food Safety Authority, Oberschleissheim/D; A. Ehrhardt, Max von Pettenkofer-Institute, Munich/D; A. Baiker, Bavarian Health and Food Safety Authority, Oberschleissheim/D |
| P 23 |
System of biological safety in Ukrainian Anti-Plague Station
O. Khaytovych, L. Zinich, O. Pavlenko, I. Ilichov, Ukrainian Anti-Plague Station - Ministry of Health of Ukraine, Simferopol/UA |
| P 24 |
Analysing cultivable and uncultivable airborne microfungi from various workplaces
D. Davolos, INAIL-exISPESL, Rome/I; L. Nelli, Siena Biotech/I; B. Pietrangeli, INAIL-exISPESL, Rome/I |
| P 25 |
About modern problems of the biological hazards
S. Gurbanov, M. Kasimov, Republican Anti Plague Station, Baku/AZ |
| P 26 |
Inactivation methods for diagnostics and for design of reference material within European external quality assurance exercises
U. Sauer, RKI, Berlin/D; S. Hawkey, HPA, Porton Down/UK; R. Grunow, RKI, Berlin/D |
| P 27 |
Electric pad lock system. How it works.
K. Shinohara, National Institute of Infectious Diseases Japan, Musashimurayama-shi Tokyo/J; R. Komatsu, Yamato System Development Co., Ltd, Koutouk-ku/J; T. Kurata, Toyama Institute of Health, Imizu-shi/J |
| P 28 |
IVC: an example for occupational safety in an animal facility
I. Koch, Aurigon Life Science GmbH, Tutzing/D; M. Busch, TECNIPLAST DEUTSCHLAND GmbH, Hohenpeißenberg/D; G. Hager, Aurigon Life Science GmbH, Tutzing/D |
| P 29 |
CWA 15793:2008: a structured way to a biosafety culture?
Practical implications at the TWINCORE in Hanover/Germany
R. Knorr, S. Gerstel, J. Mertsching, Hanover Medical School, Hanover/D |
| P 30 |
Biosafety professional development - a scientist's guide to critical reflection
S. Hawkey, C. Shieber, J. Shallcross, N. Silman, Health Protection Agency, Porton Down/UK |
| P 31 |
Experience of integration of biorisk management programme (CWA 15793: 2008) into trainings of the staff of especially dangerous infection laboratories in Ukrainian Training Center
V. Pushkina, V. Samoylenko, Ukrainian I. I. Mechnikov Anti-Plague Science Research Institute, Odessa/UA |
| P 32 |
Case study: delivery and monitoring of biosafety compliance training in remote facilities
J. King, C. Tillo, M. Cooper, Laminar Medica, Tring/UK |
| P 33 |
The role of the Portuguese National Institute of Health in response to a bioterrorism event
A. Pelerito Gonçalves, R. Cordeiro, S. Núncio, Instituto Nacional Saúde Dr Ricardo Jorge, Lisbon/P |
| P 34 |
Renovation/reconstruction design of a BSL-3 laboratory
M. Dobrostana, Institute of Food Safety, Animal Health and Environment "BIOR" Riga/LV; L. Strömfelt, Swedish Institute for Infectious Disease Control, Stockholm/S |
| P 35 |
Capacity building for biosafety research at the University of Latvia
N. Rostoks, A. Putnina, T. Tracevska, U. Riekstina, J. Ancans, University of Latvia, Riga/LV |
| P 36 |
Transportation and biosecurity for highly pathogenic bacteria - experiences across Europe during EQADeBa exercises
S. Hawkey, HPA, Porton Down/UK; R. Grunow, RKI, Berlin/D; S. Sissonen, NIHW, Helsinki/FIN; M.S. Nuncio, INSA, Lisbon/P |
| P 37 |
The EU-project AniBioThreat - implementation of the laboratory biorisk management standard (CWA 15793) as a bridging tool for law enforcement agencies, animal and public health agencies and universities
U. Allard Bengtsson, National Veterinary Institute (SVA), Uppsala/S; H. Wisselink, Central Veterinary Institute (CVI), Lelystad/NL; A. Tierno, French Agency for Food, Environmental and Occupational Health and Safety (ANSES), Paris/F; C. Löfström, Technical University of Denmark, (DTU Food), Copenhagen/DK; J. Berglund, National Police Board (RPS), Östersund/S; B. Sundqvist, R. Knutsson, National Veterinary Institute (SVA), Uppsala/S |
|
